Takashi Matsuda Selected Research

Hyperinsulinism (Hyperinsulinemia)

9/2014

Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Matsuda Research Topics

Disease

4	Liver Cirrhosis (Hepatic Cirrhosis) 11/2022 - 06/2014
4	Fibrosis (Cirrhosis) 05/2021 - 06/2014
4	Neoplasms (Cancer) 01/2020 - 06/2011
3	Portal Hypertension 11/2022 - 09/2014
2	End Stage Liver Disease 10/2020 - 01/2019
2	Hepatic Encephalopathy 01/2019 - 09/2014
2	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2018 - 01/2017
2	Infections 06/2014 - 03/2006
2	Neuroblastoma 04/2013 - 06/2011
1	Hepatitis B 11/2022
1	Liver Diseases (Liver Disease) 11/2022
1	Coinfection 11/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2022
1	Thrombophlebitis 10/2021
1	COVID-19 10/2021
1	Hypertension (High Blood Pressure) 10/2021
1	Hyperammonemia 10/2020
1	Liver Failure 10/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Hypersensitivity (Allergy) 01/2019
1	Hepatic Infarction 01/2019
1	Thrombophilia 01/2019
1	Diabetes Mellitus 09/2017
1	Glucose Intolerance 09/2017
1	Macular Edema 01/2017
1	Inflammation (Inflammations) 01/2017
1	Retinal Diseases 01/2017
1	Bites and Stings (Sting) 01/2017
1	Heart Arrest (Cardiac Arrest) 03/2015
1	Non-alcoholic Fatty Liver Disease 09/2014
1	Esophageal and Gastric Varices (Esophageal Varices) 09/2014
1	Hyperinsulinism (Hyperinsulinemia) 09/2014
1	Insulin Resistance 09/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2014
1	Dehydration (Water Stress) 04/2013
1	Pain (Aches) 06/2012
1	Hyperalgesia 06/2012
1	Diabetic Neuropathies (Diabetic Neuropathy) 06/2012

Drug/Important Bio-Agent (IBA)

3	LigandsIBA 08/2014 - 06/2012
2	AmmoniaIBA 10/2020 - 09/2017
2	SodiumIBA 10/2020 - 01/2019
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2019 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 03/2018 - 04/2013
2	Glucose (Dextrose)FDA LinkGeneric 09/2017 - 06/2012
2	Prolyl OligopeptidasesIBA 04/2013 - 06/2011
1	Antiviral Agents (Antivirals)IBA 11/2022
1	lenvatinibIBA 10/2021
1	macitentanIBA 10/2021
1	BuffersIBA 05/2021
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	AlloysIBA 01/2019
1	MetalsIBA 01/2019
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2018
1	N(epsilon)-hexanoyllysineIBA 03/2018
1	Bevacizumab (Avastin)FDA Link 03/2018
1	Retinaldehyde (Retinal)IBA 01/2017
1	human AOC3 proteinIBA 01/2017
1	Insulin (Novolin)FDA Link 09/2014
1	Liposomes (Liposome)IBA 08/2014
1	APTIBA 08/2014
1	Nucleotide AptamersIBA 01/2014
1	SaltsIBA 04/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 04/2013
1	ImmunophilinsIBA 06/2012
1	Streptozocin (Streptozotocin)FDA Link 06/2012
1	FK1706IBA 06/2012
1	Retinoblastoma ProteinIBA 06/2011
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2011
1	ThiazolidinesIBA 06/2011
1	Cyclin-Dependent Kinase Inhibitor p27IBA 06/2011
1	Cyclin EIBA 06/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2006
1	QuinolonesIBA 03/2006

Therapy/Procedure

6	Therapeutics 11/2022 - 06/2014
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2019 - 09/2014
2	Drug Therapy (Chemotherapy) 11/2022 - 10/2020
2	Catheters 10/2021 - 01/2017
1	Bariatric Surgery 01/2022
1	Immunotherapy 01/2020
1	Intravenous Infusions 01/2019
1	Lasers (Laser) 01/2017
1	Light Coagulation 01/2017
1	Complete Denture (Dentures, Complete) 01/2017
1	Cardiopulmonary Resuscitation (CPR) 03/2015
1	Local Anesthesia 06/2014
1	Oral Administration 06/2012